SCHEMBL4550080

SCHEMBL4550080

CC(O)c1ccc2ccc(OCc3nc4cc(C(=O)NO)ccc4c(=O)[nH]3)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 3/20 0.40
HDAC6 Q9UBN7 5/20 0.39
HDAC3 O15379 4/20 0.39
HDAC1 Q13547 4/20 0.39
HDAC2 Q92769 4/20 0.39
HDAC8 Q9BY41 4/20 0.39
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2611365 0.88 ROCK2 (0.44) KDM4ERECQLRAB9AHDAC6ALDH1A1
SCHEMBL4550064 0.84 KDM4E (0.46) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2611393 0.82 RAB9A (0.49) KDM4ERECQLRAB9AHDAC6HDAC8
SCHEMBL2611274 0.79 HTT (0.51) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2619420 0.78 KDM4E (0.49) KDM4ERECQLRAB9AHDAC6HDAC8
SCHEMBL2118827 0.77 RAB9A (0.47) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2611268 0.77 HDAC6 (0.46) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2619265 0.75 KMT2A (0.47) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2115685 0.75 KDM4E (0.52) KDM4ERECQLRAB9AHDAC6HDAC3
SCHEMBL2611379 0.74 ROCK2 (0.53) KDM4ERECQLRAB9AHDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054332-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-26 WO disclosed